SEC Form 4 · accession 0001209191-15-074446
Aclaris Therapeutics, Inc. · ACRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rick Bierly
Director
Period of report
Oct 6, 2015
Accepted (ET)
Oct 6, 2015 · 8:35 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001557746
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $11.00 | Oct 6, 2015 | A | 17,800 | A | — | Oct 5, 2025 | Common Stock | 17,800 | 17,800 | D |
Explanation of responses
- F1The shares underlying this option will vest in a series of 36 equal monthly installments, subject to the reporting person's continuous service with the Issuer as of each such vesting date.